Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	78,960	66,583	59,858	58,554	50,335
Revenue Growth (YoY)	18.59%	11.23%	2.23%	16.33%	-0.30%
Cost of Revenue	31,466	25,357	23,185	22,864	19,269
Gross Profit	47,494	41,225	36,673	35,690	31,065
Selling, General & Admin	14,463	15,780	13,069	11,805	10,272
Other Operating Expenses	18,342	12,762	11,597	10,562	8,606
Operating Expenses	36,647	32,052	27,459	24,835	21,402
Operating Income	10,847	9,173	9,214	10,855	9,663
Interest Expense	-1,758	-1,949	-1,629	-1,325	-1,140
Interest & Investment Income	-	207.59	118.34	101.97	69.87
Currency Exchange Gain (Loss)	55.24	48.12	-29.88	222.54	30.33
Other Non Operating Income (Expenses)	672.61	-205.93	-137.55	-124.92	-66.8
EBT Excluding Unusual Items	9,817	7,274	7,536	9,730	8,557
Merger & Restructuring Charges	-	-99.31	-	-	-
Gain (Loss) on Sale of Investments	-	25.32	1.21	-	-
Gain (Loss) on Sale of Assets	-	71.92	-3.33	-4.08	4.29
Other Unusual Items	-103.78	-	-61.46	-	-153.82
Pretax Income	9,713	7,272	7,472	9,725	8,407
Income Tax Expense	2,639	1,997	1,854	2,700	2,334
Earnings From Continuing Operations	7,075	5,276	5,618	7,026	6,073
Earnings From Discontinued Operations	-	-	-	-	-1,887
Net Income to Company	7,075	5,276	5,618	7,026	4,186
Minority Interest in Earnings	-261.35	-293.92	-298.26	-403.56	-264.47
Net Income	6,813	4,982	5,320	6,622	3,921
Net Income to Common	6,813	4,982	5,320	6,622	3,921
Net Income Growth	36.76%	-6.36%	-19.66%	68.86%	369.04%
Shares Outstanding (Basic)	187	181	181	181	181
Shares Outstanding (Diluted)	187	181	181	181	181
Shares Change (YoY)	3.40%	0.01%	-	-	-
EPS (Basic)	36.43	27.54	29.42	36.62	21.68
EPS (Diluted)	36.43	27.54	29.42	36.62	21.68
EPS Growth	32.28%	-6.38%	-19.66%	68.90%	369.23%
Free Cash Flow	6,299	8,215	3,563	3,900	5,790
Free Cash Flow Per Share	33.68	45.42	19.70	21.57	32.02
Dividend Per Share	3.000	-	2.000	3.000	1.000
Dividend Growth	-	-	-33.33%	200.00%	-60.00%
Gross Margin	60.15%	61.92%	61.27%	60.95%	61.72%
Operating Margin	13.74%	13.78%	15.39%	18.54%	19.20%
Profit Margin	8.63%	7.48%	8.89%	11.31%	7.79%
Free Cash Flow Margin	7.98%	12.34%	5.95%	6.66%	11.50%
EBITDA	14,689	11,805	11,446	12,911	12,419
EBITDA Margin	18.60%	17.73%	19.12%	22.05%	24.67%
D&A For EBITDA	3,841	2,632	2,232	2,057	2,756
EBIT	10,847	9,173	9,214	10,855	9,663
EBIT Margin	13.74%	13.78%	15.39%	18.54%	19.20%
Effective Tax Rate	27.17%	27.45%	24.81%	27.76%	27.77%
Revenue as Reported	79,633	67,152	60,317	59,189	50,674
Advertising Expenses	-	2,788	1,828	1,633	1,220

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.